AI assistant
BIOGEN INC. — Director's Dealing 2011
Apr 8, 2011
30291_dirs_2011-04-08_5785e6b1-51a6-4490-9934-3e87ed5e5297.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIOGEN IDEC INC. (BIIB)
CIK: 0000875045
Period of Report: 2011-03-05
Reporting Person: Clancy Paul J (Executive VP and CFO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2011-03-05 | Common Stock | M | 28750 | $58.99 | Acquired | 73085 | Direct |
| 2011-03-05 | Common Stock | F | 25888 | $71.15 | Disposed | 47197 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2011-03-05 | Stock Option (Right to Buy) | $58.99 | M | 28750 | Disposed | 2011-03-05 | Common Stock (28750) | Direct |
Footnotes
F1: The stock option was automatically exercised on a net share settlement basis immediately before its expiration, in accordance with its terms. The Company delivered to the reporting person the number of shares underlying the stock option less the number of shares having a Fair Market Value on the date of such exercise equal to (i) the aggregate exercise price for the stock option and (ii) the amount necessary to satisfy any federal, state and local withholding taxes related to such exercise.
F2: The stock option became exercisable in five (5) equal annual installments, commencing one year after the grant date of 3/5/2001